Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M35,089Revenue $M9,021Net Margin (%)6.2Z-Score3.5
Enterprise Value $M33,335EPS $2.6Operating Margin %14.0F-Score4
P/E(ttm))59.1Cash Flow Per Share $5.0Pre-tax Margin (%)13.1Higher ROA y-yN
Price/Book4.110-y EBITDA Growth Rate %3.7Quick Ratio1.8Cash flow > EarningsY
Price/Sales3.75-y EBITDA Growth Rate %-7.2Current Ratio2.2Lower Leverage y-yN
Price/Cash Flow10.8y-y EBITDA Growth Rate %10.8ROA % (ttm)3.6Higher Current Ratio y-yN
Dividend Yield %1.4Insider Buy (3m)0ROE % (ttm)6.8Less Shares Outstanding y-yY
Payout Ratio %73.0Shares Outstanding M378ROI % (ttm)10.8Gross Margin Increase y-yN

Gurus Latest Trades with SYK

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SYKYacktman Fund 2014-12-31 Reduce-0.68%$79.2 - $96.61
($88.75)
$ 92.754%Reduce -21.93%3,435,000
SYKYacktman Focused Fund 2014-12-31 Reduce-0.67%$79.2 - $96.61
($88.75)
$ 92.754%Reduce -22.37%2,717,000
SYKRay Dalio 2014-09-30 Buy 0.01%$79.25 - $85.63
($82.24)
$ 92.7513%New holding, 10341 sh.10,341
SYKDodge & Cox 2014-09-30 Buy $79.25 - $85.63
($82.24)
$ 92.7513%New holding, 4170 sh.4,170
SYKYacktman Focused Fund 2014-09-30 Reduce-0.28%$79.25 - $85.63
($82.24)
$ 92.7513%Reduce -8.62%3,500,000
SYKGeorge Soros 2014-09-30 Reduce-0.2%$79.25 - $85.63
($82.24)
$ 92.7513%Reduce -18.45%1,368,566
SYKDonald Yacktman 2014-09-30 Reduce-0.2%$79.25 - $85.63
($82.24)
$ 92.7513%Reduce -5.72%9,596,895
SYKYacktman Fund 2014-09-30 Reduce-0.15%$79.25 - $85.63
($82.24)
$ 92.7513%Reduce -4.62%4,400,000
SYKGeorge Soros 2014-06-30 Add0.38%$76.72 - $86.08
($81.62)
$ 92.7514%Add 52.75%1,678,108
SYKMario Gabelli 2014-06-30 Buy 0.01%$76.72 - $86.08
($81.62)
$ 92.7514%New holding, 20100 sh.20,100
SYKJoel Greenblatt 2014-06-30 Sold Out $76.72 - $86.08
($81.62)
$ 92.7514%Sold Out0
SYKYacktman Focused Fund 2014-06-30 Reduce-0.83%$76.72 - $86.08
($81.62)
$ 92.7514%Reduce -20.21%3,830,000
SYKDonald Yacktman 2014-06-30 Reduce-0.48%$76.72 - $86.08
($81.62)
$ 92.7514%Reduce -12.19%10,178,928
SYKYacktman Fund 2014-06-30 Reduce-0.21%$76.72 - $86.08
($81.62)
$ 92.7514%Reduce -5.86%4,613,000
SYKRay Dalio 2014-06-30 Sold Out -0.01%$76.72 - $86.08
($81.62)
$ 92.7514%Sold Out0
SYKGeorge Soros 2014-03-31 Add0.52%$74.63 - $83.35
($79.36)
$ 92.7517%Add 144.14%1,098,618
SYKKen Fisher 2014-03-31 Reduce$74.63 - $83.35
($79.31)
$ 92.7517%Reduce -82.85%3,410
SYKYacktman Focused Fund 2014-03-31 Reduce-0.24%$74.63 - $83.35
($79.31)
$ 92.7517%Reduce -5.88%4,800,000
SYKDonald Yacktman 2014-03-31 Reduce-0.11%$74.63 - $83.35
($79.31)
$ 92.7517%Reduce -3.05%11,592,319
SYKJoel Greenblatt 2014-03-31 Reduce-0.01%$74.63 - $83.35
($79.36)
$ 92.7517%Reduce -59.31%2,788
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SYK is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
SYK Yacktman Fund 2014-12-313,435,0000.912.7-21.93%
SYK Yacktman Focused Fund 2014-12-312,717,0000.722.8-22.37%
SYK Dodge & Cox 2014-09-304,17000New Buy
SYK Ray Dalio 2014-09-3010,34100.01New Buy
SYK Ken Fisher 2014-09-303,53500+6.48%
SYK Vanguard Health Care Fund 2014-09-301,433,5000.380.3
SYK PRIMECAP Management 2014-09-30304,5000.080.03
SYK Robert Olstein 2014-09-3098,0000.031
SYK Mario Gabelli 2014-09-3020,1000.010.01
SYK Donald Yacktman 2014-09-309,596,8952.543.2-5.72%
SYK George Soros 2014-09-301,368,5660.360.82-18.45%
Premium Most recent portfolio changes are included for Premium Members only!


SYK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
STRYKER RONDA EDirector 2014-12-31Sell14,000$95.95-3.54view
STRYKER RONDA EDirector 2014-12-29Sell28,000$95.04-2.62view
Owen Katherine AnnV.P., Strategy & Investor Rel. 2014-12-22Sell30,000$94.84-2.41view
STRYKER RONDA EDirector 2014-12-22Sell7,000$94.77-2.34view
STRYKER RONDA EDirector 2014-12-19Sell21,000$93.51-1.03view
STRYKER RONDA EDirector 2014-12-16Sell21,000$92.20.38view
STRYKER RONDA EDirector 2014-12-11Sell21,000$93.5-1.02view
STRYKER RONDA EDirector 2014-12-08Sell14,000$94.87-2.45view
STRYKER RONDA EDirector 2014-12-04Sell21,000$94.18-1.73view
STRYKER RONDA EDirector 2014-12-01Sell14,000$93.41-0.92view

Press Releases about SYK :

    Quarterly/Annual Reports about SYK:

    News about SYK:

    Articles On GuruFocus.com
    Weekly Insider Sells Highlight: ADP, KMX, SYK, DVA Jan 05 2015 
    Medovex Is A Strong Buy Dec 29 2014 
    Diamond Hill Adds Two Companies to Portfolio in Third Quarter Dec 11 2014 
    Medical Technology Company Offers Investment Opportunity Sep 25 2014 
    Pain Relief and Profits Jul 27 2014 
    Companies That Give Shareholders a Raise Feb 14 2014 
    Ken Fisher’s Top Increases of the Fourth Quarter Jan 15 2014 
    Stocks with the Greatest Net Guru Buying in Q2 Sep 09 2013 
    Forecasting Future Earnings Is the Key to Successful Stock Investing, Consensus Analysts’ Estimate Mar 14 2013 
    Solid but expensive Feb 23 2013 

    More From Other Websites
    Trim Positions in Stryker Ahead of Fourth-Quarter Earnings; Buy on Pullback Jan 26 2015
    Will Stryker (SYK) Disappoint this Earnings Season? - Analyst Blog Jan 23 2015
    Covidien Q1 Earnings Beat Estimates As Buyout Nears Jan 22 2015
    J&J Earnings Beat But Sales, Guidance Miss Jan 20 2015
    CONMED Announces Preliminary FY14 Results, Guides FY15 - Analyst Blog Jan 15 2015
    Zeltiq, Stryker, St. Jude Move On Prelim Q4 Reports Jan 14 2015
    Limited downside seen in Stryker Jan 14 2015
    STRYKER CORP Files SEC form 8-K, Results of Operations and Financial Condition Jan 14 2015
    Stryker Announces Preliminary Q4 Results, 2015 Foreign Exchnage Outlook Jan 13 2015
    Stryker expects strong dollar to hit 2015 profit Jan 13 2015
    Orthopedic device maker Stryker sees currency hitting profit Jan 13 2015
    Stryker Provides 2014 Preliminary Results and Updates 2015 Foreign Exchange Outlook Jan 13 2015
    Stryker Provides 2014 Preliminary Results and Updates 2015 Foreign Exchange Outlook Jan 13 2015
    Stryker to Present at Investor Conference Jan 05 2015
    Stryker to Present at Investor Conference Jan 05 2015
    BUZZ-U.S. STOCKS ON THE MOVE- Automobile stocks, Kite Pharma, Zimmer Jan 05 2015
    Stryker Acquires the Assets of CHG Hospital Beds, Inc. Jan 05 2015
    Stryker Acquires the Assets of CHG Hospital Beds, Inc. Jan 05 2015
    New Year's resolution stocks Dec 30 2014
    Stryker planning takeover offer for Smith & Nephew - Bloomberg Dec 24 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK